ZA851536B - Brain-specific analogues of centrally acting amines - Google Patents

Brain-specific analogues of centrally acting amines

Info

Publication number
ZA851536B
ZA851536B ZA851536A ZA851536A ZA851536B ZA 851536 B ZA851536 B ZA 851536B ZA 851536 A ZA851536 A ZA 851536A ZA 851536 A ZA851536 A ZA 851536A ZA 851536 B ZA851536 B ZA 851536B
Authority
ZA
South Africa
Prior art keywords
brain
centrally acting
specific analogues
acting amines
amines
Prior art date
Application number
ZA851536A
Other languages
English (en)
Inventor
Nicholas S Bodor
Original Assignee
Univ Florida
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Florida filed Critical Univ Florida
Publication of ZA851536B publication Critical patent/ZA851536B/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/81Amides; Imides
    • C07D213/82Amides; Imides in position 3
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/54Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
    • A61K47/559Redox delivery systems, e.g. dihydropyridine pyridinium salt redox systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/80Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D211/84Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
    • C07D211/90Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pyridine Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Cephalosporin Compounds (AREA)
  • Quinoline Compounds (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Saccharide Compounds (AREA)
ZA851536A 1984-02-29 1985-02-28 Brain-specific analogues of centrally acting amines ZA851536B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US58480084A 1984-02-29 1984-02-29

Publications (1)

Publication Number Publication Date
ZA851536B true ZA851536B (en) 1986-10-29

Family

ID=24338848

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA851536A ZA851536B (en) 1984-02-29 1985-02-28 Brain-specific analogues of centrally acting amines

Country Status (7)

Country Link
EP (1) EP0174342B1 (it)
JP (1) JPS61501562A (it)
AU (1) AU593209B2 (it)
DE (1) DE3574869D1 (it)
IT (1) IT1182713B (it)
WO (1) WO1985003937A1 (it)
ZA (1) ZA851536B (it)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5079366A (en) * 1987-04-07 1992-01-07 University Of Florida Quarternary pyridinium salts
US4888427A (en) * 1987-04-07 1989-12-19 University Of Florida Amino acids containing dihydropyridine ring systems for site-specific delivery of peptides to the brain
US5002935A (en) * 1987-12-30 1991-03-26 University Of Florida Improvements in redox systems for brain-targeted drug delivery
US5017566A (en) * 1987-12-30 1991-05-21 University Of Florida Redox systems for brain-targeted drug delivery
US5177064A (en) * 1990-07-13 1993-01-05 University Of Florida Targeted drug delivery via phosphonate derivatives
IL106998A0 (en) * 1992-09-17 1993-12-28 Univ Florida Brain-enhanced delivery of neuroactive peptides by sequential metabolism
WO1999012572A1 (en) 1997-09-10 1999-03-18 University Of Florida Compounds and method for the prevention and treatment of diabetic retinopathy

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH335521A (de) * 1955-06-02 1959-01-15 Cilag Ag Verfahren zur Herstellung neuer quaternärer Salze
AU538526B2 (en) * 1980-07-01 1984-08-16 Ici Australia Limited Isoquinoline derivatives
EP0221588A3 (en) * 1982-05-18 1988-09-21 University Of Florida Brain-specific drug delivery
US4519289A (en) * 1984-01-09 1985-05-28 Gauger Gary L Adjustable circumference floor tom stand

Also Published As

Publication number Publication date
EP0174342A1 (en) 1986-03-19
IT1182713B (it) 1987-10-05
EP0174342B1 (en) 1989-12-20
DE3574869D1 (de) 1990-01-25
WO1985003937A1 (en) 1985-09-12
IT8547751A0 (it) 1985-02-28
AU593209B2 (en) 1990-02-08
JPS61501562A (ja) 1986-07-31
IT8547751A1 (it) 1986-08-28
AU3997185A (en) 1985-09-24

Similar Documents

Publication Publication Date Title
PL256012A1 (en) Method of obtaining peptides
DE3571613D1 (en) Preparation of (threo)-1-aryl-2-acylamido-3-fluoro-1-propanols
EP0155193A3 (en) Methods of assay
PL253107A1 (en) Method of obtaining novel 2/n-substituted guanidine/-4-heteroarylthiazoles
IL75533A (en) Preparation of heteroaryloxyacetamides
GB8509322D0 (en) Determination of microconstituent
ZA851536B (en) Brain-specific analogues of centrally acting amines
GB8704890D0 (en) Protection of proteins
GB8507789D0 (en) Preparation of 2-amino-s-triazines
IL76989A0 (en) Preparation of isocyanates
JPS6416730A (en) Manufacture of amide
IL76249A0 (en) Preparation of fluoroformates
GB8517881D0 (en) Preparation of elixir
DE3566540D1 (en) Preparation of fluoropyridines
EP0155135A3 (en) Methods of assay
GB2160204B (en) Preparation of amine derivatives
PT79823B (en) Process for the preparation of n-(naphtyl-alquil)-hydroxilamines
GB8520403D0 (en) Preparation of aminolactone
GB8422162D0 (en) Preparation of alkyfurans
IL76216A0 (en) Preparation of sulphonylisoureas and-thioureas
GB8429529D0 (en) Stabilization of amines
GB8432449D0 (en) Preparation of n-acyl-derivatives of aspartame
PL250251A1 (en) Method of obtaining novel peptide analogues of encephaline
NZ227556A (en) 1-alkoxy-1-methylethoxy amines
GB8416158D0 (en) Amines